A carregar...
Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer
BACKGROUND: Triple-negative breast cancer (TNBC) represents an aggressive breast cancer subtype with historically poor overall outcomes, due primarily to a lack of effective targeted agents. Chemotherapy has been the primary treatment approach, although immune checkpoint inhibitors (ICIs) are curren...
Na minha lista:
| Publicado no: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7517981/ https://ncbi.nlm.nih.gov/pubmed/33014143 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920909091 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|